Furthermore, it has been reported that SHMT2 is highly expressed in glioma, intrahepatic cholangiocarcinoma, and hepatocellular carcinoma (12), reflecting that SHMT2 is partly involved in the process of tumorigenicity (10, 12, 13). Here, SHMT2 is linked to hepatocellular carcinoma.